AssayQuant
Edit info- Founded: 2015
- Location: Marlborough, MA
- Employee range: 11 - 50
- Funding: <10M
assayquant.com linkedin.com job board
Business:
Fluorescence Microplate Assays
About:
AssayQuant Technologies is developing robotic lab technologies to automate high-throughput screening (HTS). To support the discovery of effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious conditions, AssayQuant is creating a suite of technologies that enable HTS. For example, AssayQuant’s proprietary PhosphoSens® Technology uses novel, fluorogenic sensors in enzyme recognition to aid in the discovery of drugs that affect kinase or phosphatase function. Kinases and phosphatases are enzymes that often become dysfunctional in disease. AssayQuant’s direct, real-time kinetic assay therefore enables better decisions regarding target biology and generation of lead candidates to empower faster movement through the drug discovery process.
Jobs:
News:
Need a quicker, easier way to quantitatively measure kinase activity for your lead drug candidates?
While standard endpoint assays are labor-intensive and resource-consuming, our PhosphoSens® Conti
linkedin
Nov 23, 2024
Science/business updates
external-link
Probing the function of key proteins - MIT News
googlenews
Jan 12, 2017
Science/business updates
external-link
Did you know that continuous assays can identify lag time that endpoint assays miss?
Lag time can indicate an issue with experimental design, reagents, autophosphorylation, or biological mechanisms
linkedin
Dec 9, 2024
Science/business updates
external-link
The advantages of time-dependent inhibitors in drug development are clear, but proper characterization is key.
At #DiscoveryOnTarget2024, AssayQuant Technologies presented a workflow that addresses
linkedin
Nov 23, 2024
Science/business updates
external-link
Are you able to recognize saturation in your progress curves?
With a continuous assay, you can identify and diagnose saturation in your progress curves. Causes of saturation could include substrate
linkedin
Dec 9, 2024
Science/business updates
external-link
Tyrosine Kinase Inhibitors Market to Surpass USD 53.23 Billion by 2030 | AssayQuant, AstraZeneca, Bayer - openPR
googlenews
Mar 4, 2024
Science/business updates
external-link
Happy Holidays from AssayQuant. We’re celebrating with Kinome Trees!
Our Kinome Tree Mapping Application supports both preset and custom visualization schemes. Whether you prefer traditional binary
linkedin
Dec 16, 2024
Science/business updates
external-link
What’s more festive than a Kinome Tree!
Transform your kinome profiling data into beautiful, publication-ready visualizations in minutes. Whether you're studying compound selectivity or exploring o
linkedin
Dec 17, 2024
Science/business updates
external-link
Future Labs Capital Announces Additional Investment in AssayQuant Technologies, Inc. - AccessWire
googlenews
Mar 12, 2024
Funding-related
external-link
Nordic Biosite on LinkedIn: #kinase #phosphatase #assay #research #technology #nordicbiosite…
crunchbase
Jul 1, 2024
Science/business updates
external-link
Measure phosphorylation in real-time without manual intervention and generate a kinase activity progress curve in every well with our PhosphoSens® Continuous Kinase Assay.
Set up a single well for e
linkedin
Nov 23, 2024
Science/business updates
external-link
Is the rate of your kinetic assay reliable?
If you’re running endpoint assays, you’ve probably approximated your reaction rate from a few timepoints assuming the reaction is linear with time. But w
linkedin
Nov 23, 2024
Science/business updates
external-link
Did you know that relying solely on IC50 values can be misleading when evaluating time-dependent inhibitors?
At #DiscoveryOnTarget2024, we presented a novel approach to TDI characterization. Our post
linkedin
Nov 23, 2024
Science/business updates
external-link
Are you missing progress curve lags in your kinase assays?
Lag time can indicate an issue with experimental design, reagents, autophosphorylation, or biological mechanisms related to compound target
linkedin
Dec 2, 2024
Science/business updates
external-link
Vibliome Therapeutics and AssayQuant Technologies, Inc. Establish Collaborative Relationship
crunchbase
Aug 2, 2022
Science/business updates
external-link
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com